## Findings

- **F1 — MEDIUM — [agents/stock-filings-reader.md:22](/private/tmp/claude-501/-Users-ali/d4c86359-2e4c-4fbd-8343-299aea24f480/scratchpad/consult2/agents/stock-filings-reader.md:22):** The reader must report a conflict with the rulebook over foreign issuer 20-F/6-K results, but R10B5-A now includes them. That would manufacture a conflict, contrary to the spec’s evidence and accuracy rules (§1). **Fix:** remove the instruction; use the rulebook’s current scope.
- **F2 — MEDIUM — [agents/stock-filings-reader.md:22](/private/tmp/claude-501/-Users-ali/d4c86359-2e4c-4fbd-8343-299aea24f480/scratchpad/consult2/agents/stock-filings-reader.md:22):** “Apply R10B5-B” leaves the Item 408(a) comparison’s issuer scope unclear. The [SEC compliance guide](https://www.sec.gov/resources-small-businesses/small-business-compliance-guides/insider-trading-arrangements-and-related-disclosures) places that disclosure in 10-Q/10-K, creating a risk of false foreign issuer gaps under the spec’s honest-gap rule (§1). **Fix:** limit the comparison to applicable 10-Q/10-K disclosures. The platform task should clarify that scope in `RULEBOOK_FILINGS.md`, separately from Form 4/5 checkboxes.
- **F3 — LOW — [agents/stock-filings-reader.md:3](/private/tmp/claude-501/-Users-ali/d4c86359-2e4c-4fbd-8343-299aea24f480/scratchpad/consult2/agents/stock-filings-reader.md:3), [line 11](/private/tmp/claude-501/-Users-ali/d4c86359-2e4c-4fbd-8343-299aea24f480/scratchpad/consult2/agents/stock-filings-reader.md:11):** The stated brief and input gate omit fields required by `CONTRACT.md`. The contract overrides them, but the mismatch can cause avoidable `BLOCKED` runs. **Fix:** refer to the contract gate.

Revised file: [revised/round4/agents/stock-filings-reader.md](/private/tmp/claude-501/-Users-ali/d4c86359-2e4c-4fbd-8343-299aea24f480/scratchpad/consult2/revised/round4/agents/stock-filings-reader.md) (829 words; original 832).

**Acceptance checks using SNDK samples:**

1. Report the inventory’s two annuals and six interims as limited coverage, without claiming three and eight were reviewed.
2. Classify the 2026-11-02 sale of 600 shares at $1,158.26 as a Form 4 sale under a disclosed plan, without alleging a violation.
3. Treat the 2026-09-17 Form 144 notice for 33,841 shares as a proposed sale, not execution.
4. Identify the 2026-10-29 EX-99.1 by its content as an earnings release, not a transcript.

COUNTS: HIGH=0 MEDIUM=2 LOW=1
CONVERGED: yes